MannKind Corporation

MannKind Corporation

Healthcare

NASDAQ:MNKD · NASDAQ Global Market

Market Cap $1.13B Beta 1.11 P/E (TTM) -47.2
$3.66 -2.40%

-$0.09 today

52W Low $2.23High $6.51

Vol 3.84M · Avg 5.83M

EPS (TTM)-$0.08
Biotechnology

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-11.5%

avg 21.1%

ROIC

5.8%

avg -6.8%

ROA

0.7%

avg -50.1%

Analysis

ROIC is currently the strongest return metric at 5.8% versus its period average of -6.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management
NameTitleCompensationTenureAgeShares OwnedOwnership %

Michael E. Castagna

Chief Executive Officer & Director$1.61M50$82,781.000.03%

David Thomson

Executive Vice President, General Counsel & Secretary$1.02M59$826,299.000.27%

Stuart A. Tross

Chief People & Workplace Officer$812,215.0059$1.03M0.33%

Christopher Prentiss

Chief Financial Officer$753,319.0051$338,924.000.11%

Dominic Marasco

President of Endocrine Business Unit$717,723.0054$344,246.000.11%

Sanjay Singh

Executive Vice President of Technical Operations$364,529.0060$221,000.000.07%

Ajay Ahuja

Executive VP & Chief Medical Officer56$221,000.000.07%

Insider Trading

SEC Form 4 transactions — last 12 months

Management

Buys

1

$259,000.00

Sells

11

$2.98M

Net Sentiment

$2.72M

Net selling

Most Active

Castagna Michael

4 transactions

DateInsiderTypeSharesPriceValue
May 12, 2026

Thomson David

Direct

Sell3.0K$3.29$9,978.57
May 12, 2026

Binder Steven B.

Direct

Sell16.9K$3.29$55,732.60
Mar 10, 2026

Castagna Michael

Direct

Buy100.0K$2.59$259,000.00
Jan 8, 2026

Tross Stuart A

Direct

Sell47.0K$6.33$297,547.98
Dec 17, 2025

Castagna Michael

Direct

Sell65.8K$6.01$395,482.04
Dec 16, 2025

Castagna Michael

Direct

Sell21.3K$6.00$127,860.00
Dec 2, 2025

Castagna Michael

Direct

Sell107.9K$5.57$601,114.40
Dec 2, 2025

Thomson David

Direct

Sell147.8K$5.57$823,134.60
Nov 14, 2025

Singh Sanjay R

Direct

Sell18.8K$5.03$94,448.31
Sep 16, 2025

Tross Stuart A

Direct

Sell47.0K$5.34$250,980.00

1–10 of 12

Analysis

Insiders reported 1 buys worth $259,000.00 and 11 sells worth $2.98M over the last 12 months. That adds up to net selling of $2.72M. Castagna Michael was the most active insider with 4 transactions.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A6 analysts
RevenueN/AN/AN/A
N/A7 analysts
Net IncomeN/AN/AN/A
N/A7 analysts
EBITN/AN/AN/A
N/A7 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Who manages MNKD?

MannKind Corporation (MNKD) lists 7 active executives. The top listed executive is Stuart A. Tross, Chief People & Workplace Officer.

Are MNKD insiders buying or selling?

Recent insider activity shows net selling of $6.51M.

Explore More

Continue the stock analysis

Jump to another research area for this company.